Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Anticancer Res ; 43(3): 1245-1253, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36854519

ABSTRACT

BACKGROUND/AIM: Aurelianolide A and B were identified and isolated from Aureliana fasciculata var. fasciculata leaves. Withanolides are naturally occurring C-28 steroidal lactone triterpenoids with cytotoxic and anticancer properties, among other relevant pharmacological activities. Herein we have described, for the first time, the cytotoxic effects of aurelianolides on human cancer cells. MATERIALS AND METHODS: Aurelianolide A and B were tested on human leukemia cell lines: THP-1, MOLT-4, Jurkat, K562 and K562-Lucena 1. RESULTS: For aurelianolide A, MOLT-4 had the lower IC50 (1.17 µM) and for aurelianolide B, Jurkat was the most susceptible cell line (IC50 2.25 µM). On the other hand, the multidrug resistant (MDR) cell line K562-Lucena 1 showed higher IC50 for both aurelianolides. Using 293T, a non-tumor embryonic kidney cell line, we observed an excellent selectivity index for both aurelianolides, from 2.24 (aurelianolide B in K562-Lucena 1) to 45.5 (aurelianolide A in MOLT-4). Aurelianolide A and B activated caspase 3/7 with consequent induction of apoptosis on Jurkat and K562-Lucena 1 cell lines. We have not observed induction of necrosis. CONCLUSION: Aurelianolides A and B have important cytotoxic effects on human leukemia cell lines by the activation of the caspase pathway.


Subject(s)
Apoptosis , Leukemia , Humans , Proteolysis , Leukemia/drug therapy , Necrosis , Caspases
2.
Mem Inst Oswaldo Cruz ; 116: e200603, 2021.
Article in English | MEDLINE | ID: mdl-34495083

ABSTRACT

BACKGROUND: In March 2020, the World Health Organization (WHO) launched the Solidarity Program, probably the largest global initiative to encourage and support research in four promising drugs, named Remdesivir, Hydroxychloroquine, ß Interferon and the combination Lopinavir / Ritonavir, to reduce the mortality of Coronavirus disease 2019 (COVID-19). OBJECTIVES: Considering the potential impact of Solidarity Program to restrain the current pandemic, the present study aims to investigate whether it was designed upon indicators of scientific productivity, defined as the level of the production of new scientific knowledge and of the institutional capabilities, estimated in terms of scientific publications and technological agreements. METHODS: The scientific documents on Alphacoronavirus, Betacoronavirus, Gammacoronavirus and Coronavirus were retrieved from Scopus database while the technological agreements on coronavirus were obtained through Cortellis. As for the institutions and countries, we have considered the data on author's affiliations in both set of data. For comparison, we included the analysis of documents related with other drugs or therapies, such as vaccines and antibodies, which were listed in a Clarivate's report on coronaviruses research. FINDINGS: Most of the analysis refers to documents on Coronavirus, the largest group. The number of documents related to WHO's drugs are almost five times higher than in the other groups. This subset of documents involves the largest and most diverse number of institutions and countries. As for agreements, we observed a smaller number of institutions involved in it, suggesting differences between countries in terms of technical and human capabilities to develop basic and/or clinical research on coronavirus and to develop new forms or products to treat or to prevent the disease. MAIN CONCLUSIONS: Hence, the results shown in this study illustrate that decisions taken by an international scientific body, as WHO, were mainly based in scientific knowledge and institutional competencies.


Subject(s)
Antiviral Agents , COVID-19 , Antiviral Agents/therapeutic use , Drug Combinations , Humans , SARS-CoV-2 , World Health Organization
3.
Mem. Inst. Oswaldo Cruz ; 116: e200603, 2021. tab, graf
Article in English | LILACS | ID: biblio-1340225

ABSTRACT

BACKGROUND In March 2020, the World Health Organization (WHO) launched the Solidarity Program, probably the largest global initiative to encourage and support research in four promising drugs, named Remdesivir, Hydroxychloroquine, β Interferon and the combination Lopinavir / Ritonavir, to reduce the mortality of Coronavirus disease 2019 (COVID-19). OBJECTIVES Considering the potential impact of Solidarity Program to restrain the current pandemic, the present study aims to investigate whether it was designed upon indicators of scientific productivity, defined as the level of the production of new scientific knowledge and of the institutional capabilities, estimated in terms of scientific publications and technological agreements. METHODS The scientific documents on Alphacoronavirus, Betacoronavirus, Gammacoronavirus and Coronavirus were retrieved from Scopus database while the technological agreements on coronavirus were obtained through Cortellis. As for the institutions and countries, we have considered the data on author's affiliations in both set of data. For comparison, we included the analysis of documents related with other drugs or therapies, such as vaccines and antibodies, which were listed in a Clarivate's report on coronaviruses research. FINDINGS Most of the analysis refers to documents on Coronavirus, the largest group. The number of documents related to WHO's drugs are almost five times higher than in the other groups. This subset of documents involves the largest and most diverse number of institutions and countries. As for agreements, we observed a smaller number of institutions involved in it, suggesting differences between countries in terms of technical and human capabilities to develop basic and/or clinical research on coronavirus and to develop new forms or products to treat or to prevent the disease. MAIN CONCLUSIONS Hence, the results shown in this study illustrate that decisions taken by an international scientific body, as WHO, were mainly based in scientific knowledge and institutional competencies.


Subject(s)
Humans , Antiviral Agents/therapeutic use , COVID-19 , World Health Organization , Drug Combinations , SARS-CoV-2
4.
Protein Expr Purif ; 159: 21-26, 2019 07.
Article in English | MEDLINE | ID: mdl-30836141

ABSTRACT

l-asparaginase catalyzes the conversion of l-asparagine to l-aspartate and ammonium. This protein is an important therapeutic enzyme used for the treatment of acute lymphoblastic leukemia. In this study, the asparaginase II-encoding gene ASP3 from Saccharomyces cerevisiae was cloned into the expression vector pET28a in-fusion with a 6x histidine tag and was expressed in Escherichia coli BL21 (DE3) cells. The protein was expressed at a high level (225.6 IU/g cells) as an intracellular and soluble molecule and was purified from the supernatant by nickel affinity chromatography. The enzyme showed very low activity against l-glutamine. The denaturing electrophoresis analysis indicated that the recombinant protein had a molecular mass of ∼38 kDa. The native enzyme was a tetramer with a molecular mass of approximately 178 kDa. The enzyme preparation showed antitumor activity against the K562 and Jurkat cell lines comparable or even superior to the E. coli commercial asparaginase.


Subject(s)
Antineoplastic Agents/metabolism , Asparaginase/genetics , Bacterial Proteins/genetics , Escherichia coli/metabolism , Recombinant Proteins/genetics , Saccharomyces cerevisiae/genetics , Antineoplastic Agents/chemistry , Asparaginase/chemistry , Asparaginase/metabolism , Asparagine/metabolism , Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Cell Line, Tumor , Cloning, Molecular , Gene Expression , Glutamine/metabolism , Humans , Molecular Weight , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism
5.
Int. j. high dilution res ; 10(36): 183-193, september 30, 2011.
Article in English | LILACS-Express | HomeoIndex Homeopathy | ID: hom-10706

ABSTRACT

Aveloz é uma planta da família Euphorbiaceae, caracterizada pela produção de um látex tóxico, que quando em contato com mucosas e pele tem ação corrosiva. O uso tópico e contínuo deste látex vem sendo indicado na medicina popular para tratamento de verrugas, e epiteliomas. Para validar o uso popular da Aveloz, o látex ultradiluído e o medicamento homeopático Euphorbia tirucalli L. foram testados in vitro sobre a proliferação de células de melanoma. O látex ultradiluído foi obtido através do processo de diluiçaõ e agitação (método de trituração para fase sólida e sucussão para fase líquida), usando EtOH 70ºGL( Álcool etílico de alcoolatura de 70° Gay Lussac) como insumo inerte nas diluições homeopáticas de 5cH, 15cH e 30cH, conforme preconizado pela Farmacopeia Homeopática Brasileira(FHB). O medicamento homeopático Euphorbia tirucalli foi obtida a partir da tintura-mãe e preparado pelo método hahnemanniano na escala centesimal. Soluções de EtOH 70º GL (0,5 e 5%) foram sucussionadas e usadas como controle neste experimento. Células de melanoma humano foram cultivadas, tratadas e monitoradas pelo método MTT no intervalo de tempo de 24h a 72h. Observou-se que a solução de EtOH 0,5% teve pouco ou nenhum efeito sobreInt J High Dilution Res 2011; 10(36):183-193Proceedings of the XXV GIRI Symposium and VIII CBFH; 2011 Sep 04-07; Foz do Iguaçu (Brazil)190a proliferação de células de melanoma (inibição máxima de 5,1% no grupo 30cH ). Na maioria dos grupos, observou-se uma correlação positiva entre o grau de inibição da proliferação e a diluição dos preparativos, máximo de aumento de 9% no grupo do látex 5%. Além disso, a tintura mãe foi mais ativa do que o látex , no tratamento com 0,5% de látex 30cH mostrou uma inibição de 19,7%, enquanto no tratamento com 0,5% do medicamento homeopático Euphorbia tirucalli 30cH houve uma inibição de 32,1% da proliferação celular (p<0.05). Estes resultados sugerem um possível uso terapêutico do Aveloz em ultra-diluições. (AU)


Aveloz (firestick cactus; Euphorbia tirucalli L.) belongs to Euphorbiaceae family, characterized by the production of a toxic latex that has corrosive effects on the skin and mucous membranes. Continual topic use of the latex is recommended by popular medicine to treat warts, and epitheliomas. To validate this indication, ultra diluted latex and homeopathic medicine Euphorbia tirucalli were tested in vitro on the proliferation of melanoma cells. Ultra diluted latex was prepared in homeopathic dilutions 5cH, 15cH and 30cH by dilution and agitation (trituration for solid and sucussion for liquid phases) using 70º GL (Gay Lussac) ethylic alcohol (70º GL EtOH 70ºGL) as inert medium according to the guidelines in Farmacopéia Homeopática Brasileira (FHB). Homeopathic medicine Euphorbia tirucalli was prepared from mother-tincture according to the centesimal Hahnemannian method. Solutions 0.5% and 5% of 70ºGL EtOH were succussed and used as control. Human melanoma cells were cultured, treated and monitored by method MTT for 24 to 72 hours. It was observed that 0.5% 70ºGL EtOH solution had little or no effect on the proliferation of melanoma cells (5.1% maximal inhibition in dilution 30cH). Positive correlation was observed in most groups between inhibition of proliferation and diluted preparations, maximal increase (9%) was seen in with 5% latex. Moreover, mother-tincture proved to be more active than latex; treatment with 0.5% solution of latex 30cH exhibited 19.7% inhibition, whereas treatment with 0.5% solution of Euphorbia tirucalli 30cH exhibited 32.1% inhibition of cell proliferation (p<0.05). These results suggest that high dilutions of firestick cactus (especially dilution 30cH) might have a therapeutic indication in melanoma, further studies are needed in this regard.(AU)


Subject(s)
Euphorbia , Latex/toxicity , Melanoma , Antibodies, Neoplasm , High Potencies
6.
Lab Invest ; 91(1): 33-42, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20714326

ABSTRACT

Mast cells are involved in immune disorders so that many of the proinflammatory and tissue destructive mediators produced by these cells have been implicated in the pathogenesis of rheumatoid arthritis. This scenario prompted us to investigate the correlation between mast cell degranulation and neutrophil influx within the digits and knees joints of arthritic mice assessing what could be the functional role(s) of joint mast cells in the response to collagen immunization. DBA/1J mice were submitted to collagen-induced arthritis and disease was assessed on day 21, 32 and 42 post-immunization. Pharmacological treatment with the glucocorticoid prednisolone, commonly used in the clinic, and nedocromil, a mast cell stabilizer, was performed from day 21 to 30. Arthritis develop after immunization, gradually increased up to day 42. Neutrophil infiltration peaked on day 32 and 21, in the digits and knees, respectively, showing an unequal pattern of recruitment between these tissues. This difference emerged for mast cells: they peaked in the digits on day 21, but a higher degree of degranulation could be measured in the knee joints. Uneven modulation of arthritis occurred after treatment of mice with prednisolone or nedocromil. Neutrophils migration to the tissue was reduced after both therapies, but only prednisolone augmented mast cell migration to the joints. Nedocromil exerted inhibitory properties both on mast cell proliferation and migration, more effectively on the digit joints. Thus, collagen induced an inflammatory process characterized by tissue mast cells activation and degranulation, suggesting a potential driving force in propagating inflammatory circuits yielding recruitment of neutrophils. However, the different degree of affected joint involvement suggests a time-related implication of digits and knees during collagen-induced arthritis development. These results provide evidence for local alterations whereby mast cells contribute to the initiation of inflammatory arthritis and may be targeted in intervention strategies.


Subject(s)
Arthritis, Experimental/immunology , Mast Cells/immunology , Neutrophil Infiltration/immunology , Neutrophils/immunology , Animals , Anti-Inflammatory Agents/pharmacology , Arthritis, Experimental/drug therapy , Arthritis, Experimental/pathology , Forelimb/drug effects , Forelimb/pathology , Glucocorticoids/pharmacology , Hindlimb/drug effects , Hindlimb/pathology , Knee Joint/drug effects , Knee Joint/immunology , Knee Joint/pathology , Leukocyte Count , Mast Cells/drug effects , Mast Cells/pathology , Mice , Mice, Inbred DBA , Nedocromil/pharmacology , Neutrophil Infiltration/drug effects , Neutrophils/drug effects , Neutrophils/pathology , Prednisolone/pharmacology , Synovial Membrane/drug effects , Synovial Membrane/immunology , Synovial Membrane/pathology , Time Factors
7.
Mem. Inst. Oswaldo Cruz ; 102(8): 983-990, Dec. 2007. ilus, graf, tab
Article in English | LILACS | ID: lil-471848

ABSTRACT

An important cytokine role in dengue fever pathogenesis has been described. These molecules can be associated with haemorrhagic manifestations, coagulation disorders, hypotension and shock, all symptoms implicated in vascular permeability and disease worsening conditions. Several immunological diseases have been treated by cytokine modulation and dexamethasone is utilized clinically to treat pathologies with inflammatory and autoimmune ethiologies. We established an in vitro model with human monocytes infected by dengue virus-2 for evaluating immunomodulatory and antiviral activities of potential pharmaceutical products. Flow cytometry analysis demonstrated significant dengue antigen detection in target cells two days after infection. TNF-alpha, IFN-alpha, IL-6 and IL-10 are produced by in vitro infected monocytes and are significantly detected in cell culture supernatants by multiplex microbead immunoassay. Dexamethasone action was tested for the first time for its modulation in dengue infection, presenting optimistic results in both decreasing cell infection rates and inhibiting TNF-alpha, IFN-alpha and IL-10 production. This model is proposed for novel drug trials yet to be applyed for dengue fever.


Subject(s)
Humans , Cytokines/drug effects , Dengue Virus/drug effects , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Immunologic Factors/pharmacology , Monocytes/virology , Antigens, Viral/analysis , Cytokines/biosynthesis , Dengue Virus/immunology , Immunoenzyme Techniques , Interferon-alpha/biosynthesis , Interferon-alpha/drug effects , Interleukins/biosynthesis , Monocytes/immunology , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/drug effects
8.
Biochim Biophys Acta ; 1773(2): 176-84, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17081636

ABSTRACT

Adhesive interactions play important roles in coordinating T cell migration and activation, which are mediated by binding of integrins to RGD motif found on extracellular matrix proteins. Disintegrins, isolated from snake venoms, contain the RGD sequence that confers selectivity to integrin interaction. We have investigated the ability of three RGD-disintegrins, ligands of alpha(5)beta(1) and alpha(v)beta(3), Flavoridin (Fl), Kistrin (Kr) and Echistatin (Ech), in modulating the activation of human T lymphocyte. The disintegrins induced T cell proliferation and CD69 expression. This activation parallels with actin cytoskeleton reorganization and tyrosine phosphorylation. Furthermore, the peptides induced focal adhesion kinase (FAK) and phosphoinositide 3-kinase (PI3K) activation. Finally, RGD-disintegrins were capable of driving NF-kappaB nuclear translocation and c-Fos expression, in a PI3K and ERK1/2 activities dependent manner. This report is the first to show that RGD-disintegrins interact with integrins on human T lymphocyte surface, modulating cell proliferation and activation of specific pathways coupled to integrin receptor.


Subject(s)
Disintegrins/pharmacology , Integrins/metabolism , Lymphocyte Activation/drug effects , Oligopeptides/pharmacology , Signal Transduction/drug effects , T-Lymphocytes/drug effects , Actins/metabolism , Animals , Antigens, CD/immunology , Antigens, Differentiation, T-Lymphocyte/immunology , Cell Nucleus/drug effects , Cell Proliferation/drug effects , Cytoskeleton/drug effects , Enzyme Activation/drug effects , Focal Adhesion Protein-Tyrosine Kinases/metabolism , Humans , Lectins, C-Type , Lymphocyte Activation/immunology , NF-kappa B/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phosphotyrosine/metabolism , Protein Binding/drug effects , Protein Transport/drug effects , Proto-Oncogene Proteins c-fos/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/enzymology , T-Lymphocytes/immunology
9.
Mem Inst Oswaldo Cruz ; 102(8): 983-90, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18209938

ABSTRACT

An important cytokine role in dengue fever pathogenesis has been described. These molecules can be associated with haemorrhagic manifestations, coagulation disorders, hypotension and shock, all symptoms implicated in vascular permeability and disease worsening conditions. Several immunological diseases have been treated by cytokine modulation and dexamethasone is utilized clinically to treat pathologies with inflammatory and autoimmune etiologies. We established an in vitro model with human monocytes infected by dengue virus-2 for evaluating immunomodulatory and antiviral activities of potential pharmaceutical products. Flow cytometry analysis demonstrated significant dengue antigen detection in target cells two days after infection. TNF-alpha, IFN-alpha, IL-6 and IL-10 are produced by in vitro infected monocytes and are significantly detected in cell culture supernatants by multiplex microbead immunoassay. Dexamethasone action was tested for the first time for its modulation in dengue infection, presenting optimistic results in both decreasing cell infection rates and inhibiting TNF-alpha, IFN-alpha and IL-10 production. This model is proposed for novel drug trials yet to be applied for dengue fever.


Subject(s)
Cytokines/drug effects , Dengue Virus/drug effects , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Immunologic Factors/pharmacology , Monocytes/virology , Antigens, Viral/analysis , Cytokines/biosynthesis , Dengue Virus/immunology , Humans , Immunoenzyme Techniques , Interferon-alpha/biosynthesis , Interferon-alpha/drug effects , Interleukins/biosynthesis , Monocytes/immunology , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/drug effects
10.
Exp Cell Res ; 312(19): 3939-48, 2006 Nov 15.
Article in English | MEDLINE | ID: mdl-17010337

ABSTRACT

Heme is a proinflammatory molecule able to cause a profound delay of constitutive apoptosis of human neutrophils, an effect that likely contributes to chronic inflammation associated with hemolytic diseases. Herein we show that heme-induced delay of neutrophil apoptosis correlates with the prevention of mitochondrial potential (Deltapsi(m)) dissipation by a mechanism dependent on NADPH oxidase (NADPHox)-generated reactive oxygen species (ROS) and NF-kappaB. Deltapsi(m) maintenance is accompanied by inhibition of Bax insertion into mitochondria and by a decrease in the Bad/Bcl-X(L) ratio. Heme induces Bad degradation in a completely ROS-dependent manner, as well as Bcl-X(L) synthesis, a phenomenon that also requires NF-kappaB activation. These data indicate that heme-induced preservation of mitochondrial integrity is a critical checkpoint controlled by NADPH oxidase generated-ROS and redox-sensitive NF-kappaB activation.


Subject(s)
Heme/metabolism , Heme/pharmacology , NADPH Oxidases/metabolism , Neutrophils/drug effects , Neutrophils/metabolism , Reactive Oxygen Species/metabolism , Apoptosis/drug effects , Humans , In Vitro Techniques , Membrane Potentials/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , NF-kappa B/metabolism , Neutrophils/cytology , Oxidation-Reduction , bcl-2-Associated X Protein/metabolism , bcl-Associated Death Protein/metabolism , bcl-X Protein/metabolism
11.
Int Immunopharmacol ; 6(3): 465-72, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16428082

ABSTRACT

The mechanisms involved in the mitogenic effect of lectins are not fully understood and are thought to involve a cascade of intracellular signals related to T cell receptor activation. This study shows that frutalin, the alpha-D-galactose-binding lectin from Artocarpus incisa seeds, is a potent mitogenic activator of human lymphocytes. This effect is inhibited by D-galactose and PI3K inhibitors, and is accompanied by an increase in IL-2 receptor expression and by a PI3K-dependent IL-2 gene expression and IL-2 protein synthesis. Frutalin also induces Akt-phosphorylation and activates NF-kappaB, inducing its translocation from the cytosol to the nucleus. Both effects are blocked in the presence of D-galactose or by PI3K inhibitors. In summary, frutalin, interacting with alpha-D-galactose, activates signaling pathways related to TCR, and thereby triggers PI3K/Akt and NF-kappaB pathway, which modulates T cell proliferation, IL-2 synthesis and IL-2R expression. Frutalin might be a useful tool to study intracellular mechanisms following T cell activation that link upstream signaling pathways to downstream events.


Subject(s)
Lymphocytes/drug effects , NF-kappa B/physiology , Phosphatidylinositol 3-Kinases/physiology , Plant Lectins/pharmacology , Proto-Oncogene Proteins c-akt/physiology , Signal Transduction/immunology , Active Transport, Cell Nucleus/drug effects , Artocarpus , Humans , Interleukin-2/biosynthesis , Interleukin-2/genetics , Lymphocytes/enzymology , Mitogens/pharmacology , Receptors, Interleukin-2/biosynthesis , Receptors, Interleukin-2/genetics , Seeds , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...